In 2000 and at five-year review in 2005, which diseases are not mentioned. - Answer Cardiovascular disease and other chronic diseases
In 2000 and at five-year review in 2005, what are the 3 of 8 focused on health - Answer Reduce child mortality.
Improve maternal maternity. Prevent the sp...
PHC 6003 Final Exam With Already
Passed Answers.
In 2000 and at five-year review in 2005, which diseases are not mentioned. - Answer Cardiovascular
disease and other chronic diseases
In 2000 and at five-year review in 2005, what are the 3 of 8 focused on health - Answer Reduce child
mortality.
Improve maternal maternity. Prevent the spread of HIV/AIDS and other diseases
Myths about Cardiovascular Disease in Developing Countries - Answer CVD affects only men
CVD only affects older people
CVD only affects the rich.
A CVD epidemic is inevitable.
CVD prevention programs are not affordable.
Factors influencing the epidemiologic transition - Answer Urbanization
Industrialization
Affluence (disposable income)
Commerce
Education
Public health technology
Medical technology
thrifty genotype - Answer genes that promoted storage of energy as fat and considered advantageous
to survival during famine are detrimental now because of access to calorie-rich foods.
Thrifty genotype increases the risk of ? - Answer Metabolic syndrome and CVD
,Global View of Heart Disease and Stroke in 21st Century - Answer Cardiovascular Disease is the leading
cause of death worldwide
Leading cause in developed countries for >50 years
Leading cause in developing countries since late 1990's
True/Flase: 85% of CVD death and disability occurs in low-and-middle-income countries. - Answer True
Explanations for CVD Trends in the U.S. Since 1990 - Answer Continued improvements in secondary
prevention
Inability of health care system to provide e;ective primary prevention
Stagnation of public health campaigns to reduce deleterious health behaviors
Trends of smoking in the U.S. Since 1990* - Answer stable at 25% of adults
TRENDS IN HYPERTENSION DETECTION, TREATMENT, AND CONTROL SINCE 1990 - Answer STABLE OR
MODESTLY IMPROVED
DIABETES PREVALENCE SINCE 1990 - Answer INCREASED 14% TO 28%
TRENDS OF PHYSICAL ACTIVITY SINCE 1990 - Answer 40% OF ADULTS ARE SEDENTARY AND ONLY 26%
ARE REGULARLY ACTIVE
TRENDS IN DIETARY IN CHOLESTEROL AND SATURATED FAT SINCE 1990 - Answer REDUCED
TRENDS IN CARBOHYDRATES (+23%) AND CALORIES SINCE 1990 - Answer INCREASED
TRENDS OF OBESITY SINCE 1990 - Answer IN EPIDEMIC PROPORTIONS
T/F: Chronic disease burdens are the same between countries and regions, with di;erences explained by
the epidemiologic transition. - Answer F
, T/F: Large incidences in cardiovascular and other chronic diseases are expected in low income countries,
explained by many factors. - Answer T
T/F: Cardiovascular disease burdens in US enjoyed constant declines up to 2010, but the mortality rates
and number of deaths have leveled o;. - Answer T
Reasons To Believe Some Countries Will Be Quickly and Severely Affected by Cardiovascular Disease -
Answer Rapid growth in population aged 60+ years.
Thrifty phenotype:
High prevalences of hypertension, smoking, diabetes result in rapid rise in CVD with increases in blood
lipid levels.
T/F: In utero or early childhood deprivation predisposes persons to metabolic syndrome and CVD. -
Answer T
T/F: The impact of hypertension, diabetes, and smoking remain unchanged in setting of low LDL-C (e.g.
Asia-Paci6c, Caribbean) as compared to normal to high LDL-Cs - Answer F ( Reduced impact)
T/F: The effect of LDL-C is potentiated in presence of hypertension, diabetes, and smoking (Eastern
Europe) - Answer T
T/F: Disease profiles in low LDL-C societies was not impacted by hypertension, diabetes, smoking. -
Answer F (still negatively impacted)
Management of risk factors of CVD in low risk populations - Answer Public health measures and
lifestyle modifications
Management of risk factors of CVD in moderate risk populations - Answer RF management with less
aggressive thresholds and goals.
Management of risk factors of CVD in moderate risk populations - Answer Agressive RF management,
prophylactic therapies
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller TestSolver9. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for £8.40. You're not tied to anything after your purchase.
